Botanical species · safety record

Acalypha hispida

The EFSA Compendium of Botanicals holds 8 constituent measurements for Acalypha hispida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Acalypha hispida Burm.f.

8Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids2
  • 1,8-dihydroxyanthraquinone derivatives1
  • Cardenolides1
  • Cardiac glycosides1
  • Labdane diterpenes1
  • Saponins1
  • Tannins1

Plant parts

  • Aerial part of plants4
  • Leaves3
  • Flower1

Preparations

  • Solvent extraction7
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-dihydroxyanthraquinone derivativesLeavesSolvent extractionPhytochemical screeningResolve DOI
AlkaloidsLeavesSolvent extractionNo resolvable identifier
AlkaloidsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
CardenolidesAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesLeavesSolvent extractionNo resolvable identifier
Labdane diterpenesFlowerEssential oil12.75 Percent AreaGC-MSNo resolvable identifier
SaponinsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Iniaghe, O.M., Malomo, S.O., Adebayo, J.O. Proximate composition and phytochemical constituents of leaves of some Acalypha species. Pakistan Journal of Nutrition, 2009, vol. 8, no. 3, p. 256-258. DOI
  2. Soladoye, Mike O., Sonibare, Mubo A., Rosanwo, Temitope O. Phytochemical and morphometric analysis of the genus Acalypha Linn. (Euphorbiaceae).. Journal of Applied Sciences, 2008, vol. 8, no. 17, p. 3044-3049.
  3. Manikanta, B., Varma, P.R., Krishna, V., Kumar, A.R., Rathinam, K.M.S. Phytochemical evaluation of Acalypha hispida, Acalypha nervosa and Acalypha fruiticosa. Journal of Chemical and Pharmaceutical Sciences, 2014, vol. 7, no. 3, p. 197-199.
  4. Onocha, P. A., Oloyede, G. K., Bamkole, O. A. Volatile oil composition, cytotoxicity and free radical scavenging activity of the leaves and twigs of the chenille plant (Acalypha hispida).. International Journal of Essential Oil Therapeutics, 2010, vol. 4, no. 3-4, p. 86-89.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue